“LHX1 As a Potential Biomarker Regulates EMT Induction and Cellular Behaviors in Uterine Corpus Endometrial Carcinoma”. Clinics, vol. 77, Sept. 2022, p. 100103, https://doi.org/10.1016/j.clinsp.2022.100103.